Target Price | $303.96 |
Price | $274.19 |
Potential |
10.86%
register free of charge
|
Number of Estimates | 16 |
16 Analysts have issued a price target ResMed 2026 .
The average ResMed target price is $303.96.
This is
10.86%
register free of charge
$341.25
24.46%
register free of charge
$217.15
20.80%
register free of charge
|
|
A rating was issued by 23 analysts: 16 Analysts recommend ResMed to buy, 6 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the ResMed stock has an average upside potential 2026 of
10.86%
register free of charge
|
Jun '25 |
2026 Estimates |
|
---|---|---|
Revenue Billion $ | 5.15 | 5.65 |
9.84% | 9.79% | |
EBITDA Margin | 33.64% | 38.46% |
10.17% | 14.33% | |
Net Margin | 27.22% | 28.37% |
24.91% | 4.23% |
23 Analysts have issued a sales forecast ResMed 2026 . The average ResMed sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an ResMed EBITDA forecast 2026. The average ResMed EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
19 ResMed Analysts have issued a net profit forecast 2026. The average ResMed net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Jun '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share $ | 9.51 | 10.95 |
37.43% | 15.14% | |
P/E | 25.04 | |
EV/Sales | 7.01 |
19 Analysts have issued a ResMed forecast for earnings per share. The average ResMed EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Citigroup |
Locked
➜
Locked
|
Locked | Sep 18 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 01 2025 |
UBS |
Locked
➜
Locked
|
Locked | Aug 01 2025 |
Keybanc |
Locked
➜
Locked
|
Locked | Aug 01 2025 |
Mizuho |
Locked
➜
Locked
|
Locked | Aug 01 2025 |
Stifel |
Locked
➜
Locked
|
Locked | Aug 01 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Aug 01 2025 |
Analyst Rating | Date |
---|---|
Locked
Citigroup:
Locked
➜
Locked
|
Sep 18 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 01 2025 |
Locked
UBS:
Locked
➜
Locked
|
Aug 01 2025 |
Locked
Keybanc:
Locked
➜
Locked
|
Aug 01 2025 |
Locked
Mizuho:
Locked
➜
Locked
|
Aug 01 2025 |
Locked
Stifel:
Locked
➜
Locked
|
Aug 01 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 01 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.